Nonpegylated liposomal doxorubicin (MyocetTM) combination (R-COMP) chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL): results from the phase II EUR018 trial.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples